We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rhenovia Files Two Patent Applications for RHEpatch™

News   Mar 22, 2013

 
Rhenovia Files Two Patent Applications for RHEpatch™
 
 
 

RELATED ARTICLES

New Method to Synthesize and Screen Macrocyclic Compounds

News

Scientists at EPFL have found a way to generate libraries of more than 9,000 of macrocyclic molecules below 1 KDa, all with high structural diversity.

READ MORE

First Generic Version of EpiPen Is Approved

News

The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

READ MORE

Team Design Drug Molecule to Improve Heart Attack Recovery

News

A new molecule has been developed that could help preserve heart tissue during – and even after – a heart attack.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE